L M Staudt

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Genomic views of the immune system*
    L M Staudt
    Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Annu Rev Immunol 18:829-59. 2000
  2. ncbi Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol
    L T Lam
    Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Genome Biol 2:RESEARCH0041. 2001
  3. ncbi Gene expression physiology and pathophysiology of the immune system
    L M Staudt
    Metabolism Branch, NCI, Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892, USA
    Trends Immunol 22:35-40. 2001
  4. ncbi BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major
    A L Dent
    Metabolism Branch, National Cancer Institute, Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD, USA
    J Immunol 163:2098-103. 1999
  5. ncbi BCL-6 expression during B-cell activation
    D Allman
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 87:5257-68. 1996
  6. ncbi Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6
    L M Staudt
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Int Rev Immunol 18:381-403. 1999
  7. ncbi Signatures of the immune response
    A L Shaffer
    Metabolism Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 4N114, Bethesda, MD 20892, USA
    Immunity 15:375-85. 2001
  8. ncbi Control of inflammation, cytokine expression, and germinal center formation by BCL-6
    A L Dent
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Science 276:589-92. 1997
  9. ncbi T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6
    A L Dent
    Metabolism Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 95:13823-8. 1998
  10. ncbi LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies
    A L Dent
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 88:1423-6. 1996

Collaborators

Detail Information

Publications25

  1. ncbi Genomic views of the immune system*
    L M Staudt
    Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Annu Rev Immunol 18:829-59. 2000
    ..The databases of gene expression emerging from these studies of normal immune responses will be used to interpret the pathological changes in gene expression that accompany autoimmunity, immune deficiencies, and cancers of immune cells...
  2. ncbi Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol
    L T Lam
    Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Genome Biol 2:RESEARCH0041. 2001
    ..However, the mechanism of action of flavopiridol as an anti-cancer agent has not been fully elucidated...
  3. ncbi Gene expression physiology and pathophysiology of the immune system
    L M Staudt
    Metabolism Branch, NCI, Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892, USA
    Trends Immunol 22:35-40. 2001
    ..Comprehensive databases of gene expression measurements can be used to understand the pathological mechanisms underlying disease processes...
  4. ncbi BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major
    A L Dent
    Metabolism Branch, National Cancer Institute, Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD, USA
    J Immunol 163:2098-103. 1999
    ..These results show that STAT6 is required for susceptibility to L. major infection and suggest that IL-13 signaling through STAT6 may contribute to a nonhealing, exacerbated L. major infection...
  5. ncbi BCL-6 expression during B-cell activation
    D Allman
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 87:5257-68. 1996
    ..These observations suggest that the germinal center reaction provides unique activation signals to B cells that allow for continued, high-level BCL-6 expression...
  6. ncbi Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6
    L M Staudt
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Int Rev Immunol 18:381-403. 1999
    ..The BCL-6 protein is a potent transcriptional repressor which presumably controls lymphocyte differentiation and induces lymphomas by regulating the expression of key downstream target genes...
  7. ncbi Signatures of the immune response
    A L Shaffer
    Metabolism Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 4N114, Bethesda, MD 20892, USA
    Immunity 15:375-85. 2001
    ..Finally, the transcriptional repression signature of BCL-6 reveals how this factor can prevent terminal differentiation of B cells and cause B cell lymphomas...
  8. ncbi Control of inflammation, cytokine expression, and germinal center formation by BCL-6
    A L Dent
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Science 276:589-92. 1997
    ..Thus, dysregulation of STAT-responsive genes may underlie the inflammatory disease in BCL-6-deficient mice and participate in lymphoid malignancies...
  9. ncbi T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6
    A L Dent
    Metabolism Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 95:13823-8. 1998
    ..BCL-6, a transcriptional repressor that can bind to the same DNA binding motifs as STAT transcription factors, seems to regulate TH2 responses in vivo by a pathway independent of IL-4 and STAT6...
  10. ncbi LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies
    A L Dent
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 88:1423-6. 1996
    ..By double-immunogold labeling of PML and LYSP100, some LANDs were shown to contain both PML and LYSP100. Thus, PML is localized to a second subnuclear domain that is morphologically and biochemically distinct from PML NBs...
  11. ncbi Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
    A Rosenwald
    Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Exp Med 194:1639-47. 2001
    ..These genes were used to build a CLL subtype predictor that may help in the clinical classification of patients with this disease...
  12. ncbi Molecular definition of the germinal centre stage of B-cell differentiation
    C Ma
    Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892, USA
    Philos Trans R Soc Lond B Biol Sci 356:83-9. 2001
    ....
  13. ncbi Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
    R E Davis
    Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1374, USA
    J Exp Med 194:1861-74. 2001
    ....
  14. ncbi Stromal gene signatures in large-B-cell lymphomas
    G Lenz
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    N Engl J Med 359:2313-23. 2008
    ..Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear...
  15. ncbi Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes
    K P Wandinger
    Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1400, USA
    Ann Neurol 50:349-57. 2001
    ....
  16. ncbi A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo
    M H Rosner
    Metabolism Branch, National Cancer Institute, Bethesda, Maryland 20892
    Nature 345:686-92. 1990
    ..The oct-3 gene is also expressed in primordial germ cells and in the female germ line...
  17. ncbi Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes
    P Scherle
    Metabolism Branch, National Cancer Institute, Bethesda, MD 20892
    Proc Natl Acad Sci U S A 90:7568-72. 1993
    ....
  18. ncbi LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias
    C Ma
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 87:734-45. 1996
    ..Therefore, the cloning of LAF-4 has defined a new family of potential regulatory proteins that may function in lymphoid development and oncogenesis...
  19. ncbi Jaw1, A lymphoid-restricted membrane protein localized to the endoplasmic reticulum
    T W Behrens
    Metabolism Branch National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892
    J Immunol 153:682-90. 1994
    ..These findings suggest that the function and/or the structure of the ER in lymphocytes may be modified by lymphoid-restricted resident ER proteins...
  20. ncbi Gene regulation mediated by calcium signals in T lymphocytes
    S Feske
    Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
    Nat Immunol 2:316-24. 2001
    ..We demonstrate an elaborate network of signaling pathways downstream of the T cell receptor, explaining the complexity of changes in gene expression during T cell activation...
  21. ncbi Mapping of the mouse Bcl6 gene to chromosome 16
    X Liao
    Mammalian Genetics Laboratory, ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, USA
    Mamm Genome 7:621-2. 1996
  22. ncbi Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen
    S M Kang
    Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892
    Mol Cell Biol 12:3149-54. 1992
    ..The relatively delayed kinetics of Oct-2 induction suggests that Oct-2 mediates the changes in gene expression which occur many hours or days following antigen stimulation of T lymphocytes...
  23. ncbi Carboxyl-terminal targeting and novel post-translational processing of JAW1, a lymphoid protein of the endoplasmic reticulum
    T W Behrens
    Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA
    J Biol Chem 271:23528-34. 1996
    ..In addition, the processing of the small lumenal domain of Jaw1 represents a novel post-translational protein modification performed by the endoplasmic reticulum...
  24. ncbi Characterization of chicken octamer-binding proteins demonstrates that POU domain-containing homeobox transcription factors have been highly conserved during vertebrate evolution
    B Petryniak
    Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor 48109
    Proc Natl Acad Sci U S A 87:1099-103. 1990
    ..Together, our data show that the POU-containing subfamily of homeobox genes have been highly conserved during vertebrate evolution, apparently as a result of selection for their DNA-binding and transcriptional regulatory properties...
  25. ncbi Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
    J Iqbal
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Leukemia 21:2332-43. 2007
    ..The biological role of BCL6 in translocated cases where repression of known target genes is not demonstrated is intriguing and warrants further investigation...